In July 2022, GlaxoSmithKline completed the demerger of its consumer healthcare business to form the independent Haleon Group. It was a visionary and very necessary move. It focuses the new company’s innovation efforts on becoming a key player in the world of FMCG. And to explain this change, we invited two of its innovation leaders to be the guest speakers at our November ‘Innovation Talk’.
Shafik Saba is the global lead for ‘Front End Innovation’. Nick Tate runs NEXT – the division focused on developing disruptive growth platforms. Together, they will take us on a fascinating innovation journey.